Scotland business

Axis-Shield of Dundee agrees to takeover by Alere

Syringe and slides
Image caption Axis-Shield's recommendation to shareholders follows a three-month battle for the Dundee firm

Shares in medical diagnostics firm Axis-Shield rose after it agreed to be taken over by American company Alere.

The move came after Alere sweetened its original offer for the Dundee-based company after a three-month battle.

Axis-Shield said it would recommend that shareholders accept the 470p per share bid, which is about 2% higher than Alere's initial offer.

Its shares, which have climbed by about 34% since Alere first pitched its offer in July, rose by 4% early on Thursday.

The revised offer values the company at £235m.

Last week, Alere raised its stake in Axis-Shield to 30% - the most it could buy in the open market - and lowered its acceptance threshold from 90% to 50%.

In a stock market statement, Axis-Shield said it still considered the offer "fundamentally" undervalued the company, adding that it expected Alere's revised acceptance condition to be met against a "volatile economic and market backdrop".

Axis-Shield makes a medical testing product for diabetes, branded Afinion, and another product for rheumatoid arthritis.

It is understood Alere wants Axis-Shield primarily for its point-of-care technology, which provides immediate, portable and convenient diagnostics.

In July, Axis-Shield rejected a £230m approach from Alere, which then took the 460p offer directly to Axis-Shield's shareholders in August.

Both companies have now agreed to extend the timetable for the revised offer so that it remains open for acceptances until 24 October.

More on this story

Related Internet links

The BBC is not responsible for the content of external Internet sites